These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1316071)
61. Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones. Ouédraogo G; Morlière P; Santus R; Miranda ; Castell JV J Photochem Photobiol B; 2000 Oct; 58(1):20-5. PubMed ID: 11195848 [TBL] [Abstract][Full Text] [Related]
62. Effect of phagocytosis of bacteria on the uptake of sparfloxacin by human neutrophils. García I; Pascual A; Ballesta S; Perea EJ Chemotherapy; 1996; 42(6):465-7. PubMed ID: 8957582 [TBL] [Abstract][Full Text] [Related]
63. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials. Qadri SM; Lee GC; Ellis ME Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304 [TBL] [Abstract][Full Text] [Related]
64. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Pascual A; Garcia I; Perea EJ Antimicrob Agents Chemother; 1989 May; 33(5):653-6. PubMed ID: 2751280 [TBL] [Abstract][Full Text] [Related]
65. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections. Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948 [TBL] [Abstract][Full Text] [Related]
66. Uptake of fluoroquinolones in human monocytes isolated from peripheral blood. Dorian M; Grellet J; Saux MC J Pharm Pharmacol; 1998 Jul; 50(7):783-8. PubMed ID: 9720628 [TBL] [Abstract][Full Text] [Related]
67. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review. Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896 [TBL] [Abstract][Full Text] [Related]
68. Lomefloxacin concentrations in bone after a single oral dose. On A; Nightingale CH; Quintiliani R; Sweeney KR; Pasternak HS; Maderazo EG Am J Med; 1992 Apr; 92(4A):15S-17S. PubMed ID: 1316064 [TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of four fluoroquinolones in an animal model of infected lung. Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E J Antimicrob Chemother; 1991 Dec; 28 Suppl C():39-44. PubMed ID: 1664828 [TBL] [Abstract][Full Text] [Related]
70. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers. Beskid G; Prosser BL Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919 [TBL] [Abstract][Full Text] [Related]
71. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies. Fernandes PB; Swanson RN Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears. Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510 [TBL] [Abstract][Full Text] [Related]
73. The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect. Davidson RJ; Drobot GR; Karlowsky JA; Zhanel GG; Philips R; Hoban DJ J Antimicrob Chemother; 1994 Sep; 34(3):363-70. PubMed ID: 7829410 [TBL] [Abstract][Full Text] [Related]
74. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)]. Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259 [TBL] [Abstract][Full Text] [Related]
75. Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones. Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A J Pharm Sci; 1989 Jun; 78(6):504-7. PubMed ID: 2760827 [TBL] [Abstract][Full Text] [Related]
76. [Degradation of liquid preparations of four fluoroquinolones by factorial experiment. ]. Zhang QS; Bai ZZ; Guan DW Yao Xue Xue Bao; 1997 Dec; 32(12):931-3. PubMed ID: 11596192 [TBL] [Abstract][Full Text] [Related]
77. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones]. Iakovlev VP Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111 [No Abstract] [Full Text] [Related]
78. The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes. Nielsen SL; Obel N; Storgaard M; Andersen PL J Antimicrob Chemother; 1997 May; 39(5):617-22. PubMed ID: 9184361 [TBL] [Abstract][Full Text] [Related]
79. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones. Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789 [TBL] [Abstract][Full Text] [Related]
80. Studies on the uptake and release of fluoroquinolones by disposable contact lenses. Tian X; Iwatsu M; Sado K; Kanai A CLAO J; 2001 Oct; 27(4):216-20. PubMed ID: 11725985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]